Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland

Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer

(2012) Peng Guan et al.   INTERNATIONAL JOURNAL OF CANCER

The Biology and Life-Cycle of Human Papillomaviruses

(2012) John Doorbar et al.   VACCINE

Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland

(2012) M. K. Leinonen et al.   BMJ-British Medical Journal

Genotyping of human papillomavirus in triaging of low-grade cervical cytology

(2011) Anna Söderlund-Strand et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice

(2011) Walter Kinney et al.   GYNECOLOGIC ONCOLOGY

Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening

(2011) Dorien C. Rijkaart et al.   INTERNATIONAL JOURNAL OF CANCER

Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice

(2011) Hormuzd A Katki et al.   LANCET ONCOLOGY

Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial

(2011) Dorien C Rijkaart et al.   LANCET ONCOLOGY

Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study

(2011) Veronika Učakar et al.   VACCINE

Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia

(2010) Elena Shipitsyna et al.   Cancer Epidemiology

Population fraction of cervical neoplasia attributable to high-risk human papillomaviruses

(2010) Päivi Laukkanen et al.   Future Oncology

What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?

(2010) Warner Huh et al.   GYNECOLOGIC ONCOLOGY

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

(2010) Ni Li et al.   INTERNATIONAL JOURNAL OF CANCER

Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings

(2010) Laia Bruni et al.   JOURNAL OF INFECTIOUS DISEASES

Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection

(2010) A. C. Rodriguez et al.   JNCI-Journal of the National Cancer Institute

Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence

(2010) S. K. Kjaer et al.   JNCI-Journal of the National Cancer Institute

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY

Prevaccination Distribution of Human Papillomavirus Types in Women Attending at Cervical Cancer Screening in Belgium

(2009) M. Arbyn et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prevalence and distribution of high-risk human papillomavirus in Greece

(2009) Theodoros Agorastos et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Optimal Threshold for a Positive Hybrid Capture 2 Test for Detection of Human Papillomavirus: Data from the ARTISTIC Trial

(2009) A. Sargent et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Modified General Primer PCR System for Sensitive Detection of Multiple Types of Oncogenic Human Papillomavirus

(2009) A. Soderlund-Strand et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting

(2009) Maarit Leinonen et al.   JNCI-Journal of the National Cancer Institute

Efficacy of HPV DNA Testing With Cytology Triage and/or Repeat HPV DNA Testing in Primary Cervical Cancer Screening

(2009) P. Naucler et al.   JNCI-Journal of the National Cancer Institute

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

(2008) V M H Coupé et al.   BRITISH JOURNAL OF CANCER

Human papillomavirus infection in women with and without cervical cancer in Warsaw, Poland

(2008) A. Bardin et al.   EUROPEAN JOURNAL OF CANCER

Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3

(2008) Laura Kotaniemi-Talonen et al.   EUROPEAN JOURNAL OF CANCER

Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark

(2008) Susanne K. Kjaer et al.   INTERNATIONAL JOURNAL OF CANCER

Human Papillomavirus Genotype Specificity of Hybrid Capture 2

(2008) P. E. Castle et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries

(2008) Jack Cuzick et al.   VACCINE